Novo Nordisk and Eli Lilly deny partnership with Mangoceuticals for weight-loss drugs, causing Mangoceuticals' shares to ...

Click in for more news from The Hill {beacon} Health Care   The Big Story Democrats pivot to affordability After failing to win an extension of ObamaCare’s enhanced subsidies in ...

Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following clarification regarding its ...

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio ...

Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...

Investing.com -- Mangoceuticals Inc (NASDAQ:MGRX) stock plunged 17% Thursday after pharmaceutical giants Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) denied having partnerships with the telehealth ...

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies ...

Eli Lilly (LLY) said it “has no affiliation with Mangoceuticals. Any communication or media report suggesting a partnership between Lilly and ...

British pro-Palestinian political commentator Sami Hamdi landed back in London on Thursday (November 13) after being released ...

(Reuters) -Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the ...

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and ...